LENZ Therapeutics Inc (NASDAQ:LENZ) price on Thursday, July 03, rose 5.07% above its previous day’s close as an upside momentum from buyers pushed the stock’s value to $32.53.
A look at the stock’s price movement, the close in the last trading session was $30.96, moving within a range at $30.86 and $32.7. Turning to its 52-week performance, $38.93 and $16.53 were the 52-week high and 52-week low respectively. Overall, LENZ moved 9.27% over the past month.
LENZ Therapeutics Inc’s market cap currently stands at around $915.59 million, with investors looking forward to this quarter’s earnings report slated for on 2025-May-07.
Turning to the stock’s technical picture we see that short term indicators suggest on average that LENZ is a 100% Buy. On the other hand, the stock is on average a 100% Buy as suggested by medium term indicators while long term indicators are putting the stock in 50% Buy category.
2 analyst(s) have given their forecast ratings for the stock on a scale of 1.00-5.00 for a strong buy to strong sell recommendation. A total of 0 analyst(s) rate the stock as a Hold, 2 recommend LENZ as a Buy and 0 give it an Overweight rating. Meanwhile, 0 analyst(s) rate the stock as Underweight and 0 say it is a Sell. As such, the average rating for the stock is Buy which could provide an opportunity for investors keen on increasing their holdings of the company’s stock.
LENZ’s current price about 8.29% and 12.69% off the 20-day and 50-day simple moving averages respectively. The Relative Strength Index (RSI, 14) currently prints 63.97, while 7-day volatility ratio is 5.92% and 7.05% in the 30-day chart. Further, LENZ Therapeutics Inc (LENZ) has a beta value of 0.50. Analysts have given the company’s stock an average 52-week price target of $51, forecast between a low of $51 and high of $51. Looking at the price targets, the low is -56.78% off current price level while to achieve the yearly target high, price needs to move -56.78%. Nonetheless, investors will most likely welcome a -56.78% jump to $51 which is the analysts’ median price.
If we refocus on LENZ Therapeutics Inc (NASDAQ:LENZ), historical trading data shows that trading volumes averaged 0.37 over the past 10 days and 284.44K over the past 3 months. The company’s latest data on shares outstanding shows there are 27.54 million shares.
The 20.89% of LENZ Therapeutics Inc’s shares are in the hands of company insiders while institutional holders own 81.34% of the company’s shares. Also important is the data on short interest which shows that short shares stood at 3.4 million on 2025-06-13, giving us a short ratio of 15.08. The data shows that as of 2025-06-13 short interest in LENZ Therapeutics Inc (LENZ) stood at 2262.9999000000003 of shares outstanding, with shares short rising to 3.38 million registered in 2025-05-15. Current price change has pushed the stock 83.89% YTD, which shows the potential for further growth is there. It is this reason that could see investor optimism for the LENZ stock continues to rise going into the next quarter.
